Structure of 4'-demethylepipodophyllotoxin in complex with tubulin provides a rationale for drug design

Biochem Biophys Res Commun. 2017 Nov 4;493(1):718-722. doi: 10.1016/j.bbrc.2017.08.125. Epub 2017 Aug 30.

Abstract

Microtubules consists of αβ-tubulin heterodimers and are highly attractive targets for anti-cancer drugs. A broad range of agents have been identified to bind to tubulin and interfere with microtubule assembly, including colchicine binding site inhibitors (CBSIs). Podophyllotoxin is a CBSI that inhibits the assembly of microtubules. However, for a long time, the design and development of podophyllotoxin family drugs have been hindered by the lack of high-resolution structural information of the tubulin-agent complex. We report the first high-resolution (2.8 Å) structure of a podophyllotoxin family agent (4'-demethylepipodophyllotoxin, DMEP) complexed with tubulin and revealed the detailed interactions between DMEP and tubulin. Comparison of this structure and other CBSIs explains previous results of the structure-activity-relationship (SAR) studies, and provides insights into the development of new podophyllotoxin derivatives targeting the colchicine site.

Keywords: Colchicine domain; Crystal structure; Drug design; Podophyllotoxin; Tubulin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Drug Design*
  • Molecular Docking Simulation*
  • Podophyllotoxin / analogs & derivatives*
  • Podophyllotoxin / chemistry
  • Protein Binding
  • Protein Conformation
  • Structure-Activity Relationship
  • Tubulin / chemistry*
  • Tubulin / ultrastructure*
  • Tubulin Modulators / chemistry*

Substances

  • Tubulin
  • Tubulin Modulators
  • Podophyllotoxin
  • 4'-demethylepipodophyllotoxin